Inactive Instrument

Zeltia SA Share Price

Stocks

ES0184940817

Biotechnology & Medical Research

End-of-day quote BME
- ^EUR	-

11/11/15	Alibaba's Singles' Day sales surge 60 percent to $14.3 billion	RE
04/11/15	Alibaba : China consumers to spend more in November 11 'Singles Day' shopping spree - Nielsen	RE

Latest news : Zeltia SA

11/11/15	Alibaba's Singles' Day sales surge 60 percent to $14.3 billion	RE
04/11/15	Alibaba : China consumers to spend more in November 11 'Singles Day' shopping spree - Nielsen	RE
17/12/14	Hyundai Heavy : Thomson Reuters/INSEAD Asia Business Sentiment Survey fourth quarter 2014 - PDF	RE
17/12/14	Hyundai Heavy : Thomson Reuters/INSEAD fourth quarter Asian Business Sentiment Survey - by economy	RE
17/12/14	Hyundai Heavy : Thomson Reuters/INSEAD fourth quarter Asian Business Sentiment Survey - by sector	RE
03/11/14	Inditex : Daughter of Zara founder declares 5 percent Inditex stake	RE
05/02/14	Bell Aliant Inc : Canada tightens rules on cellphone towers	RE
17/12/13	Vodafone Group plc : Insight - The Luxembourg tax break that helps firms profit from loss	RE
18/10/13	Google Inc : Google shares break $1,000 barrier as mobile pays off	RE
18/10/13	Berkshire Hathaway Inc. : Google shares break $1,000 barrier as mobile pays off	RE
18/10/13	Canadian Solar Inc. : China's pioneers to drive recovery in solar equipment demand	RE
16/10/13	Verizon Communications Inc. : Telecom tycoon says Ottawa's policy imperils Wind, foreign investment	RE

Press Releases : Zeltia SA

26/10/15	Zeltia : PharmaMar to Present New Studies for YONDELIS® and PM1183 in Ovarian Cancer during ESGO 2015	PU
23/10/15	Zeltia : U.S. FDA Approves YONDELIS® (trabectedin) for Soft Tissue Sarcoma (Liposarcoma or Leiomyosarcoma)	PU
21/10/15	Zeltia : Grupo Zeltia reports 126.8 million euro in net sales (+8.5%) in the first nine months of 2015	PU
21/09/15	Zeltia : Enrollment of first patient in a Phase II trabectedin study in brain tumor type called meningioma	PU
17/09/15	Zeltia : PharmaMar initiates a phase II “Basket” trial for PM1183 in selected advanced solid tumors	PU

More press releases

News in other languages : Zeltia SA

14/12/15	DJ Industrial : Wall Street termine dans le vert une séance volatile
17/11/15	China CITIC Bank : Les valeurs à suivre sur les marchés américains
28/07/15	DJ Industrial : Wall Street finit en hausse, les craintes sur la Chine refluent
27/07/15	DJ Industrial : Wall Street plombée par la chute des Bourses chinoises
26/05/15	Les valeurs à suivre sur les marchés américains

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	LONZA GROUP AG	-1.16%	-3.97%	-2.91%	+13.00%	48.93B
	REVOLUTION MEDICINES, INC.	-0.40%	+1.03%	+418.57%	+527.30%	45.01B
	IQVIA HOLDINGS INC.	-1.42%	+2.30%	+42.67%	+22.37%	44.07B
	BEONE MEDICINES AG	-1.22%	-2.31%	+4.82%	+77.49%	40.73B
	CELLTRION, INC.	-0.96%	-2.31%	+15.75%	+45.41%	33.52B
	ASCENDIS PHARMA A/S	-0.21%	+9.14%	-	-	17.77B
	MEDPACE HOLDINGS, INC.	-0.35%	-1.56%	+21.42%	+120.75%	16.5B
	EUROFINS SCIENTIFIC SE	-1.54%	-1.05%	+12.16%	+29.80%	14.67B
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.65%	-1.03%	+75.93%	+41.12%	13.77B
	Average	-0.99%	+0.48%	+73.55%	+109.66%	30.55B
	Weighted average by Cap.	-1.00%	+0.05%	+88.96%	+128.42%

See all sector performances

Company Profile

Employees

-

Sector

Biotechnology & Medical Research

More about the company

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!